Literature DB >> 8955500

Evolution of maternofetal transport of immunoglobulins during human pregnancy.

A Malek1, R Sager, P Kuhn, K H Nicolaides, H Schneider.   

Abstract

PROBLEM: We determined the evolution of the maternal-fetal transport of immunoglobulins during human pregnancy.
METHOD: Paired blood samples were collected between 17-41 weeks of gestation (WG) by puncture of a peripheral maternal vein and by cordocentesis (17-36 WG, n = 91) or directly at delivery (37-41 WG n = 16) from the umbilical vein. Additional maternal samples were collected from the same individual (n = 16) at 10, 20, 30 WG, and at term. The concentration of IgG and its four subclasses and of IgA were determined in the sera using ELISA method.
RESULTS: The mean level of IgG and IgA in maternal sera at 9-16 WG was 13.72 +/- 2.53 g/L and 3.95 +/- 1.23 g/L, respectively. Both, IgG and IgA throughout pregnancy decreased to a level of 60-70% (37-41 WG) of the initial concentration in early pregnancy. The ratio of IgG1:IgG2 in the maternal circulation was 2-3 and remained constant throughout pregnancy (17-41 WG). IgG3 and IgG4 levels remained constant and together were less than 10% of total IgG. In the fetal circulation a continuous rise in the level of both IgG and IgA was observed between 17 and 41 WG. Fetal level of IgG at 17-22 WG was only 5-10% of the maternal level and at term exceeded the maternal level reaching a value of 11.98 +/- 2.18 g/L. IgG1 at 17-22 WG was 0.93 +/- 0.42 g/L, which is approximately three times higher than IgG2. IgG1 showed an exponential rise and at 37-41 WG its concentration was seven times higher than IgG2. IgG3 and IgG4 also showed an exponential rise and at term reached a similar level as in the maternal circulation. Striking was the difference in results for IgG2 with a slow linear rise throughout gestation. The fetal IgG2 level at term remained significantly below the maternal concentration. The IgG subclasses when characterized according to the differences in transport capacity gave the following sequence: IgG1 > IgG4 > IgG3 > IgG2. Fetal IgA showed a slow linear rise with fetal levels at term remaining approximately 1,000 times lower than the concentration in the maternal circulation.
CONCLUSIONS: Comparison of fetal and maternal levels of immunglobulines indicate that the human placenta during pregnancy develops a specific transport mechanism for IgG. There are differences for the four subclasses with preferential transfer of IgG1 while the slowest transfer is seen for IgG2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955500     DOI: 10.1111/j.1600-0897.1996.tb00172.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  140 in total

1.  Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy.

Authors:  A Malek; A Willi; J Müller; R Sager; W Hänggi; N Bersinger
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

Review 2.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

3.  Behavioral correlates of maternal antibody status among children with autism.

Authors:  Daniel Braunschweig; Paul Duncanson; Robert Boyce; Robin Hansen; Paul Ashwood; Isaac N Pessah; Irva Hertz-Picciotto; Judy Van de Water
Journal:  J Autism Dev Disord       Date:  2012-07

Review 4.  How nutrition and the maternal microbiota shape the neonatal immune system.

Authors:  Andrew J Macpherson; Mercedes Gomez de Agüero; Stephanie C Ganal-Vonarburg
Journal:  Nat Rev Immunol       Date:  2017-06-12       Impact factor: 53.106

5.  Two Prenatal Cases of Hyper-IgE Syndrome.

Authors:  Makiko Egawa; Kohsuke Imai; Yoko Taketani; Tomohiro Morio; Naoyuki Miyasaka
Journal:  J Clin Immunol       Date:  2019-01-07       Impact factor: 8.317

6.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 7.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

8.  Pseudothrombocytopenia in a neonate due to mother?

Authors:  J J Korterink; B Boersma; M Schoorl; L Porcelijn; P C M Bartels
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

9.  Pregnancy Outcome in Patients with Common Variable Immunodeficiency.

Authors:  Pavlina Kralickova; Barbora Kurecova; Ctirad Andrys; Irena Krcmova; Dalibor Jilek; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

10.  Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model.

Authors:  Karen May; Markus Grube; Indu Malhotra; Carole A Long; Sanjay Singh; Kishor Mandaliya; Werner Siegmund; Christoph Fusch; Henning Schneider; Christopher L King
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.